Indaptus Therapeutics, Inc.

8-K Entered a material agreement; Unregistered sale of equity Jun 24, 2026 8-K Director or officer change Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K/A Director or officer change Apr 24, 2026 8-K Director or officer change Apr 23, 2026 8-K Director or officer change Apr 3, 2026 8-K Change in control; Director or officer change Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Modified rights of security holders; Change in control; Amended charter or bylaws; Shareholder vote results Feb 27, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 12, 2026 8-K Director or officer change Jan 20, 2026 8-K Director or officer change Jan 8, 2026 8-K Director or officer change Jan 2, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Unregistered sale of equity; Shareholder vote results Jul 29, 2025 8-K Other events Jul 16, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jul 1, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jun 26, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 13, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 12, 2025 8-K Delisting notice or listing-rule failure Jan 31, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Oct 22, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 8, 2024